Arrabidaea Chica (Arrabidaea chica): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Arrabidaea chica work for wound healing?

Arrabidaea chica promotes wound healing through its active compounds carajurin and anthocyanins, which possess antioxidant and anti-inflammatory properties. These compounds help reduce oxidative stress at wound sites while supporting tissue regeneration. The tannins provide astringent effects that contract wound edges and reduce exudate. Laboratory studies suggest antimicrobial activity against certain bacteria and fungi, potentially preventing wound infection. Evidence level: C (preliminary studies and traditional use support these mechanisms, though clinical trials remain limited).

Is Arrabidaea chica safe during pregnancy and breastfeeding?

Arrabidaea chica is considered unsafe during pregnancy and should be avoided. The herb contains bioactive compounds including anthocyanins that may stimulate uterine contractions or affect fetal development, though specific teratogenic studies are lacking. There is insufficient safety data for breastfeeding women, so avoidance is recommended. Women who are pregnant, planning pregnancy, or breastfeeding should not use Arrabidaea chica internally or topically. Traditional contraindications specifically identify pregnancy as a condition prohibiting use.

What is the recommended dosage for Arrabidaea chica?

Traditional dosage for Arrabidaea chica involves preparing a leaf decoction of 200ml taken two to three times daily for internal use. For topical application, a paste made from crushed fresh leaves can be applied directly to affected skin areas or wounds. Standardized commercial preparations may have different dosage recommendations based on concentration. Due to limited clinical studies establishing optimal therapeutic doses, users should follow product labeling or consult a qualified herbalist. Evidence level: C (based primarily on traditional use).

Does Arrabidaea chica interact with any medications?

There are no well-documented drug interactions for Arrabidaea chica in current medical literature. However, due to limited clinical research, caution is advised when combining this herb with medications. The tannin content may potentially reduce absorption of certain drugs if taken simultaneously. Patients taking anticoagulants, immunosuppressants, or medications for anemia should consult a healthcare provider before use. Always separate herbal preparations from prescription medications by at least two hours to minimize potential absorption interactions.

What is Arrabidaea chica used for traditionally?

Arrabidaea chica has been used traditionally by Amazonian indigenous peoples for treating skin diseases, wounds, and fungal infections. The leaves produce a distinctive red-purple pigment used as both a natural dye and medicinal preparation. Additional traditional applications include treating anemia and providing antioxidant support. The herb is applied topically as a leaf paste for skin conditions or taken internally as a decoction. Evidence level: C (traditional use is well-documented, though clinical evidence supporting these applications remains preliminary).

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Arrabidaea chica (also known as Fridericia chica) is a medicinal vine native to the Amazon region used traditionally for inflammation, wound healing, and various systemic disorders [PMID:36139047, PMID:40474821].

Background

Arrabidaea chica (synonym Fridericia chica), commonly known as crajiru or pariri, is a plant species of the Bignoniaceae family widely distributed in Brazil and tropical America [PMID:31732026, PMID:40474821].

Traditional uses

Used in folk medicine as a tea or preparation for intestinal colic, diarrhea, anemia, inflammation, skin diseases, leukemia, blood disorders such as hemorrhage, and viral diseases including measles, chickenpox, and herpes [PMID:36139047, PMID:40474821, PMID:32756445, PMID:24009700].

Active compounds

The plant contains phenolic compounds, including flavonoids such as scutellarein (the main phenolic compound), luteolin, apigenin, isoscutellarein, 6-hydroxyluteolin, and hispidulin [PMID:31732026, PMID:34354593, PMID:24009700]. Other identified compounds include 3-desoxyanthocyanidins (carajurin, carajurone), carotenoids (lutein, $\beta$-carotene, $\alpha$-carotene), ascorbic acid, and various quinones [PMID:11324913, PMID:31732026, PMID:21772750].

Mechanism of action

The herb demonstrates antioxidant activity by scavenging reactive oxygen species (ROS) and nitrogen species (RNS) [PMID:36290636, PMID:29156345]. It promotes wound healing by favoring fibroblast proliferation and collagen production [PMID:36139047, PMID:18573628]. Specific compounds like carajurin inhibit the transcription factor NF-kappaB [PMID:11324913], and certain fractions preferentially inhibit COX-2 [PMID:33881683].

Clinical evidence

Evidence BOral Mucositis

A mucoadhesive gel containing 2.5% A. chica extract was evaluated for wound healing potential in oncohematological patients undergoing bone marrow transplantation [PMID:41394293].

Evidence DWound Healing (Animal/In Vitro)

Extracts stimulated fibroblast growth and reduced wound area in rat models [PMID:18573628, PMID:36139047].

Evidence DBreast Cancer (Animal/In Vitro)

Oral administration of extract significantly reduced breast tumor incidence in DMBA-induced rat models [PMID:31826147] and modulated estrogen and androgen receptors in luminal breast cancer cells [PMID:35057779].

Evidence DLeishmaniasis (In Vitro)

Crude extracts and isolated anthocyanidins (carajurin) showed activity against promastigote and amastigote forms of Leishmania amazonensis [PMID:34323692, PMID:34354593].

Evidence DHepatotoxicity (Animal)

Hydroethanolic extract reduced GPT, GOT, and bilirubin levels in CCl4-induced liver injury rats [PMID:21772750].

Evidence D

Safety & adverse effects

Acute and subchronic toxicity evaluations in mice and rats using hydroethanolic extract did not indicate significant toxicity at doses up to the tested levels [PMID:24070833].

Evidence summary

The evidence is primarily based on in vitro studies and animal models (Level D), with emerging randomized clinical trial data (Level B) specifically for the treatment of oral mucositis via mucoadhesive gel.

PubMed sources

1.PMID: 36139047 (2022) — Therapeutic Potential of Leaves from Fridericia chica (Bonpl.) L. G. Lohmann: Botanical Aspects, Phytochemical and Biological, Anti-Inflammatory, Antioxidant and Healing Action. · Biomolecules
2.PMID: 40474821 (2025) — Fridericia chica (Bonpl.) L.G. Lohmann: An Overview of Medicinal Plant Studies. · Journal of medicinal food
3.PMID: 32848479 (2020) — Standardized Arrabidaea chica Extract Shows Cytoprotective Effects in Zoledronic Acid-Treated Fibroblasts and Osteoblasts. · Clinical, cosmetic and investigational dentistry
4.PMID: 38931948 (2024) — Immunomodulatory and Anticancer Effects of Fridericia chica Extract-Loaded Nanocapsules in Myeloid Leukemia. · Pharmaceutics
5.PMID: 31732026 (2019) — Profile of phenolic compounds and carotenoids of Arrabidaea chica leaves and the in vitro singlet oxygen quenching capacity of their hydrophilic extract.

Arrabidaea Chica

Sources & Citations

Calculate a safe dose of Arrabidaea Chica

Ulmo

Afzelia Africana

Salvia pratensis

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources

Arrabidaea Chica

Sources & Citations

Calculate a safe dose of Arrabidaea Chica

Related Herbs

Ulmo

Afzelia Africana

Salvia pratensis

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources